The novel therapy of the medication represents a exciting breakthrough in the care of the condition. Different to existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide819658.xzblogs.com/82367975/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment